Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains from its second partial exit this year.It sold a 4.5% stake in Mumbai-listed Syngene ...
- Introduction to PE/VC Financing, The Lalit New Delhi, 20th Sep, 2018
- Workshop on Negotiation, Documentation & Structuring of PE/VC & M&A Deals, The Lalit New Delhi, 27th Sep, 2018
- An In-Depth Workshop on Fundraising Through IPO, Bengaluru, 11th Oct, 2018
- An In-Depth Workshop on Fundraising Through IPO, Delhi, 26th Oct, 2018